|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
JP2005526003A
(ja)
|
2001-10-22 |
2005-09-02 |
ファイザー株式会社 |
５−ｈｔ４受容体調節剤としてのイミダゾピリジン化合物
|
|
WO2003074525A1
(fr)
|
2002-03-01 |
2003-09-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Compose heterocyclique azote
|
|
EP1543004A1
(en)
|
2002-09-20 |
2005-06-22 |
Pfizer Inc. |
N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
CA2523077A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
|
|
BRPI0416216A
(pt)
|
2003-11-12 |
2006-12-26 |
Amicus Therapeutics Inc |
composto de glicoimidazol e polihidroxiciclohexenila e método para sintetizar composto de glicoimidazol e polihidroxiciclohexenila, métodos para inibir glicocerebrosidase, para aumentar a atividade de glicocerebrosidase e para estabilizar glicocerebrosidade, composição farmacêutica, métodos para inibir uma -glicosidade, e para tratar doença de gaucher, derivado de glicoimidazol e derivados de polihidroxiciclohexilamina
|
|
GB0329214D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
US7645756B2
(en)
|
2004-02-18 |
2010-01-12 |
Banyu Pharmaceutical Co. Ltd. |
Nitrogenous fused heteroaromatic ring derivative
|
|
EP1753422B1
(en)
|
2004-05-14 |
2008-05-28 |
The Cleveland Clinic Foundation |
Small molecule inhibitors for mrp1 and other multidrug transporters
|
|
JP4608542B2
(ja)
|
2004-06-21 |
2011-01-12 |
エフ．ホフマン−ラ ロシュ アーゲー |
ピラゾロピリミジン誘導体
|
|
EA200700368A1
(ru)
|
2004-08-02 |
2007-08-31 |
Шварц Фарма Аг |
Карбоксамиды индолизина и их аза- и диазапроизводных
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
JP5094412B2
(ja)
|
2005-01-19 |
2012-12-12 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病治療用又は予防用のジペプチジルペプチダーゼ−ｉｖ阻害剤としての二環系ピリミジン
|
|
EP1851225B1
(en)
|
2005-02-11 |
2011-06-15 |
F. Hoffmann-La Roche AG |
Pyrazolo-pyrimidine derivatives as mglur2 antagonists
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
US7767854B2
(en)
|
2005-04-21 |
2010-08-03 |
Dainippon Sumitomo Pharma Co., Ltd. |
N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
|
|
EP1878727A4
(en)
|
2005-04-28 |
2013-11-13 |
Kyowa Hakko Kirin Co Ltd |
2-AMINOQUINAZOLINE DERIVATIVES
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
CA2624500A1
(en)
|
2005-10-06 |
2007-04-19 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
US8101625B2
(en)
|
2005-10-21 |
2012-01-24 |
Exelixis, Inc. |
Pyrimidinones as Casein Kinase II (CK2) modulators
|
|
RU2008127263A
(ru)
|
2005-12-08 |
2010-01-20 |
Новартис АГ (CH) |
ПИРАЗОЛ [1,5-a] ПИРИДИН-3-КАРБОНОВЫЕ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ EphB-И VEGFR2-КИНАЗЫ
|
|
TW200800997A
(en)
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
US7829579B2
(en)
|
2006-06-23 |
2010-11-09 |
Amicus Therapeutics, Inc. |
Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
US7553846B2
(en)
|
2006-08-07 |
2009-06-30 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5-HT3 modulators
|
|
EP2102211A2
(en)
|
2006-11-20 |
2009-09-23 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
WO2008063669A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic matrix metalloprotease inhibitors
|
|
CN101801972A
(zh)
|
2007-03-28 |
2010-08-11 |
英诺瓦西亚公司 |
作为硬脂酰-辅酶a去饱和酶抑制剂的吡唑并[1,5-a]嘧啶
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
MX2009013781A
(es)
|
2007-06-21 |
2010-02-01 |
Irm Llc |
Inhibidores de cinasa de proteina y metodos para el uso de los mismos.
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
WO2009060197A1
(en)
|
2007-11-08 |
2009-05-14 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
MX2010005950A
(es)
|
2007-11-28 |
2010-06-17 |
Schering Corp |
2-fluoropirazolo[1,5-a]pirimidinas como inhibidores de proteina quinasa.
|
|
CN101981033B
(zh)
|
2008-02-06 |
2015-02-04 |
百时美施贵宝公司 |
用作激酶抑制剂的取代的咪唑并哒嗪化合物
|
|
US20110118236A1
(en)
|
2008-03-25 |
2011-05-19 |
Michiyo Mochizuki |
Heterocyclic compound
|
|
SG190603A1
(en)
|
2008-05-01 |
2013-06-28 |
Sirtris Pharmaceuticals Inc |
Quinolines and related analogs as sirtuin modulators
|
|
EP2350077B1
(en)
|
2008-10-14 |
2016-01-27 |
Entasis Therapeutics Limited |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
BRPI0914404A2
(pt)
|
2008-10-31 |
2019-03-06 |
Genentech Inc |
"compostos, composição farmacêutica e método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak quinase em um paciente"
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
GEP201706639B
(en)
|
2009-08-17 |
2017-03-27 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
CA2802641C
(en)
|
2010-07-13 |
2019-03-12 |
Nidhi Arora |
Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
ES2681218T3
(es)
|
2010-12-08 |
2018-09-12 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Pirazolopirimidinas sustituidas como activadoras de la glucocerebrosidasa
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
EP2688872A4
(en)
|
2011-03-22 |
2014-08-27 |
Merck Sharp & Dohme |
AMIDOPYRAZOLHEMMER OF INTERLEUKIN RECEPTOR-MEDIATED KINASES
|
|
CN103764166B
(zh)
|
2011-06-22 |
2017-10-24 |
通用医疗公司 |
蛋白质病的治疗
|
|
HUE026671T2
(en)
|
2011-08-18 |
2016-07-28 |
Nippon Shinyaku Co Ltd |
Heterocyclic derivatives as microsomal prostaglandin E synthetase inhibitors (mPGEs)
|
|
AU2012300844B2
(en)
|
2011-09-02 |
2017-03-30 |
Bayer Intellectual Property Gmbh |
Substituted annellated pyrimidine and the use thereof
|
|
US8961959B2
(en)
|
2011-10-17 |
2015-02-24 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
US9957271B2
(en)
|
2011-10-20 |
2018-05-01 |
Glaxosmithkline Llc |
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
|
|
AU2012355624A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
CN104470523B
(zh)
|
2012-03-09 |
2017-07-11 |
莱西肯医药有限公司 |
基于咪唑并[1,2‑b]哒嗪的化合物、包含它们的组合物及其使用方法
|
|
AU2013240187A1
(en)
|
2012-03-28 |
2014-10-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
EP2855459B1
(en)
|
2012-05-31 |
2020-04-29 |
F.Hoffmann-La Roche Ag |
Aminoquinazoline and pyridopyrimidine derivatives
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014025651A1
(en)
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
EA201590482A1
(ru)
|
2012-09-05 |
2015-07-30 |
Байер Кропсайенс Аг |
Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
|
|
CA2889919C
(en)
|
2012-11-16 |
2021-08-17 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
EP2925750A1
(en)
|
2012-11-29 |
2015-10-07 |
Karyopharm Therapeutics, Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
ES2946360T3
(es)
|
2012-12-07 |
2023-07-17 |
Vertex Pharma |
Pirazolo[1,5-a]pirimidinas útiles como inhibidores de ATR quinasa para el tratamiento de enfermedades de cáncer
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
US20160159808A1
(en)
|
2013-07-24 |
2016-06-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
US20160199372A1
(en)
|
2013-08-20 |
2016-07-14 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2895490T3
(es)
|
2014-03-27 |
2022-02-21 |
Acad Medisch Ct |
Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
ES2958391T3
(es)
|
2014-11-06 |
2024-02-08 |
Bial R&D Invest S A |
Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos
|
|
AU2015342883B2
(en)
|
2014-11-06 |
2020-07-02 |
Bial - R&D Investments, S.A. |
Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders
|
|
EP3215511B1
(en)
|
2014-11-06 |
2024-04-17 |
Bial-R&D Investments, S.A. |
Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
|
|
CN108290855A
(zh)
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途
|
|
US9802942B2
(en)
|
2015-07-01 |
2017-10-31 |
Northwestern University |
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
|
|
US20190092789A1
(en)
|
2015-09-04 |
2019-03-28 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
AR106595A1
(es)
|
2015-11-06 |
2018-01-31 |
Incyte Corp |
COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE PI3K-g
|
|
WO2017087590A1
(en)
|
2015-11-18 |
2017-05-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
CN108473501B
(zh)
|
2016-02-18 |
2021-07-16 |
豪夫迈·罗氏有限公司 |
治疗化合物、其组合物及使用方法
|
|
MX2018012208A
(es)
|
2016-04-06 |
2019-03-28 |
Lysosomal Therapeutics Inc |
Compuestos a base de imidazo [1,5-a] pirimidinil carboxamida y su uso en el tratamiento de trastornos médicos.
|
|
US11124516B2
(en)
|
2016-04-06 |
2021-09-21 |
BIAL-BioTech Investments, Inc. |
Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
EP3440080A4
(en)
|
2016-04-06 |
2020-01-22 |
Lysosomal Therapeutics Inc. |
PYRAZOLO [1,5-A] PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
EP3452045A1
(en)
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
US11168087B2
(en)
|
2016-05-05 |
2021-11-09 |
Bial—R&D Investments, S.A. |
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
|
|
WO2017192929A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO[1,2-α]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
US11345698B2
(en)
|
2016-05-05 |
2022-05-31 |
Bial—R&D Investments, S.A. |
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
|
|
US20200339587A1
(en)
|
2017-12-21 |
2020-10-29 |
Lysosomal Therapeutics Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|